CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1

Yu-Pei Yuan,Zhen-Guo Ma,Xin Zhang,Si-Chi Xu,Xiao-Feng Zeng,Zheng Yang,Wei Deng,Qi-Zhu Tang
DOI: https://doi.org/10.1016/j.yjmcc.2017.10.008
IF: 5.763
2018-01-01
Journal of Molecular and Cellular Cardiology
Abstract:•CTRP3 attenuated doxorubicin (DOX)-induced cardiac dysfunction, inflammation and cell death.•CTRP3 could activate Sirt1 in vivo and in vitro.•The deficiency of Sirt1 blocked the protective effects of CTRP3 in DOX-induced heart injury.
What problem does this paper attempt to address?